Asking questions:What I’ve learned over 10 years on Stack Overflow

I have extensive experience with the online communities (and I have addressed that issue before). The process of visibility (and then discovery) is difficult when you have millions of websites jostling for attention. Users often penalize their attention spans towards gratification (and not necessarily for "learning") despite the best intentions. It seems so easy at … Continue reading Asking questions:What I’ve learned over 10 years on Stack Overflow →

Social media for oncologists: Is it worth it?

I have been grappling with this idea repeatedly, and it isn't the last word on the subject. I might be revisiting it in the future. Twitter makes for some interesting conversations at times, but one must keep in mind that those are merely snapshots of thoughts. It can never replace the medium of a blog, … Continue reading Social media for oncologists: Is it worth it? →

Blog Redesign

I am thrilled to share the new redesign. I will be making a few more changes to accommodate a range of other planned formats. You will notice a redesigned subscription button (to get the blog updates via email) and of course, the RSS feeds at the bottom. I will follow this up with a detailed … Continue reading Blog Redesign →

Back from the Blender Conference 2019 – Fading Memories

Very instructive write up on the "free software". If the mac developers saw the light, they would immediately shift towards Linux. By keeping closed libraries, for instance, they are only delaying their own demise. They are compounding stupidity by sticking to a "Sherlockian model". It won't stop Apple from subsuming your application (if it grows … Continue reading Back from the Blender Conference 2019 – Fading Memories →

Good science, Bad Science: Why don’t we get a “cure” for cancer?

This post was "inspired" by an editorial from Scientific American (and I am riding its coattails) because I needed someone to call out the broken process. The essay does make some generalisations, however. Yet, it is still relevant because we, as scientists (and clinicians) owe it to our patients who look up to us. We … Continue reading Good science, Bad Science: Why don’t we get a “cure” for cancer? →